In vivo Hurler syndrome gene therapy program (CRISPR Therapeutics)
N/A
Report date: 2025/09/05 16:16:18
Base Information
Drug NameIn vivo Hurler syndrome gene therapy program (CRISPR Therapeutics)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrispr Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesCrispr Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A